Article metrics

Extended report
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

 

Online download statistics by month:

Online download statistics by month: July 2013 to April 2021

AbstractFullPdf
Jul 2013146131
Aug 20131609288536
Sep 20131722279480
Oct 2013882275286
Nov 2013721149184
Dec 20131830166320
Jan 2014990180333
Feb 2014503114234
Mar 2014496126164
Apr 2014326137162
May 2014270113126
Jun 2014327124124
Jul 201423310086
Aug 20141788179
Sep 201421583124
Oct 2014230110112
Nov 20141879296
Dec 20141516773
Jan 201521595137
Feb 2015222105117
Mar 20151776572
Apr 20151396364
May 20151277272
Jun 20151145072
Jul 20151106551
Aug 20151046452
Sep 20151347380
Oct 20151054574
Nov 20151215980
Dec 20151396969
Jan 20161325676
Feb 20161095148
Mar 20161097484
Apr 20161776087
May 20161335181
Jun 2016994870
Jul 20161053757
Aug 20161185870
Sep 20161084151
Oct 2016915148
Nov 20161145764
Dec 2016884731
Jan 20171305165
Feb 2017434753
Mar 20174114762
Apr 2017248856
May 2017287548
Jun 20176410640
Jul 201716010355
Aug 201719612351
Sep 20171499350
Oct 20171528987
Nov 20171607253
Dec 2017935126
Jan 20181449444
Feb 20181516748
Mar 20181999748
Apr 20181509149
May 20181277532
Jun 20181447429
Jul 20181256630
Aug 20181065830
Sep 20181258234
Oct 2018996030
Nov 2018926222
Dec 2018835725
Jan 20191108836
Feb 2019887826
Mar 2019987037
Apr 2019594122
May 2019645226
Jun 2019575134
Jul 2019675446
Aug 2019524223
Sep 2019664626
Oct 2019776655
Nov 2019624141
Dec 2019574321
Jan 2020826427
Feb 2020714635
Mar 20201319953
Apr 2020845146
May 2020925269
Jun 2020444246
Jul 2020403017
Aug 2020554535
Sep 2020845730
Oct 2020936359
Nov 20201057636
Dec 2020895022
Jan 2021725434
Feb 2021704531
Mar 2021605239
Apr 2021413224
Total1896173997320